Maximizing Inhaled Corticosteroid/Long-Acting β2-Agonist Efficacy in Asthma
In recent years, the management of asthma has become increasingly sophisticated, particularly for those suffering from moderate-to-severe forms of the ...
In recent years, the management of asthma has become increasingly sophisticated, particularly for those suffering from moderate-to-severe forms of the ...
In recent years, asthma has emerged as a significant public health concern, particularly among younger populations. The prevalence of uncontrolled ...
Inhaled therapies have long been a cornerstone in managing asthma, particularly in patients with uncontrolled asthma. This therapeutic approach aims ...
In a groundbreaking discussion on asthma management, researchers are revisiting an alarming trend concerning the over-prescription of short-acting β2-agonists (SABAs). ...
The management of asthma has historically relied on a range of pharmacological interventions, particularly short-acting β2-agonists (SABAs), for quick symptom ...
Recent advancements in the field of asthma management have shed light on the intricacies of treatable traits in patients undergoing ...
Tezepelumab, an innovative monoclonal antibody, has recently drawn attention for its potential to transform the treatment landscape for patients suffering ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine